feed,title,long_url,short_url
Benzinga,"Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope",https://benzinga.com/analyst-ratings/analyst-color/23/09/34327014/hypertension-impacts-1-2b-people-alnylams-gene-silencing-drug-candidate-hits-the-ma,https://da.gd/bwvGwM
